Welcome! You are invited to join a meeting: CVT India. After registering, you will receive a confirmation email about joining the meeting.
Cath Lab Case of the Week: Indian Masters
Related Articles
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina | NEJM
Original Article from The New England Journal of Medicine — A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina
Heart health: Salt substitutes may lower risk of death up to 10 years
A new study finds that consuming salt substitutes instead of table salt can reduce the risk of cardiovascular events and all-cause death for up to…
New trial evidence in the field of lipid management webinar on ESC 365
Access this webinar on New trial evidence in the field of lipid management and more with Professor L. Tokgozoglu (Türkiye,TR), Professor V. Aboyans (France,FR),Professor U.…
Beyond the Data: ORBITA-COSMIC
Mamas Mamas, Rasha Al-Lamee, and Michael Foley discuss treating refractory angina with a coronary sinus reducer.
Beyond the Data: ORBITA-COSMIC
Mamas Mamas, Rasha Al-Lamee, and Michael Foley discuss treating refractory angina with a coronary sinus reducer.
Beyond the Data: ORBITA-COSMIC
Mamas Mamas, Rasha Al-Lamee, and Michael Foley discuss treating refractory angina with a coronary sinus reducer.
Beyond the Data: ORBITA-COSMIC
Mamas Mamas, Rasha Al-Lamee, and Michael Foley discuss treating refractory angina with a coronary sinus reducer.
Socioeconomic Disparities in Women’s Cardiovascular Health in United States and Canada
Cardiovascular disease has been the leading cause of death in the United States and Canada for decades. Although it affects millions across a multitude of…
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina | NEJM
Original Article from The New England Journal of Medicine — A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina
Leading doctor warns of deadly unforeseen side effects of Ozempic
Best-selling nutritional expert Dr Mark Hyman said the drug’s side effects are ‘scary’ and ‘quite disturbing’ and that more undesirable effects are likely to come…